ANGO News and Press, AngioDynamics Inc. From 01/04/24

2024-01-04 10:55:52 ET More on AngioDynamics Execution Issues Continue To Undermine The AngioDynamics Story Seeking Alpha’s Quant Rating on AngioDynamics Historical earnings data for AngioDynamics Financial information for AngioDynamics For fur...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial re...

122 Patients Enrolled in Single-arm IDE Study; 30-Day Follow-up AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving pa...

2023-11-21 16:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-10-18 09:17:19 ET Summary AngioDynamics reported 6% pro forma revenue growth in Q1, but the performance of its Medical Technologies business was mixed, with a troubling contraction in thrombectomy. Major growth drivers are still a year or more away and there appear to be sign...

2023-10-05 06:11:32 ET More on AngioDynamics AngioDynamics, Inc. (ANGO) Q1 2024 Earnings Call Transcript AngioDynamics: Enormous Effort Required In Fiscal '24 To Reverse The Equity Picture AngioDynamics, Inc. (ANGO) Q4 2023 Earnings Call Transcript AngioDynam...

2023-10-04 18:15:00 ET A fairly uninspiring set of quarterly results pushed AngioDynamics (NASDAQ: ANGO) stock down in value on Wednesday. The medical device and technology company saw its share price dip by almost 3% on the day, contrasting with the 0.8% gain of the S&P 500 ...

2023-10-04 10:35:20 ET AngioDynamics, Inc. (ANGO) Q1 2024 Earnings Conference Call October 4, 2023 08:00 AM ET Company Participants Jim Clemmer - President & CEO Steve Trowbridge - EVP & CFO Conference Call Participants Jayson Bedford - Raymond Ja...

Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected to report for Q1 2024 Art's-Way Manufacturing Co. Inc. (ARTW) is expected to report for Q2 2024 Resources Connection Inc. (RGP) is expected to report $0.12 for Q1 2024 Bullfrog AI Holdings Inc. (BFRG) is expected to report for Q1 ...

Fiscal Year 2024 First Quarter Highlights Net sales of $78.7 million as reported Includes $0.7 million of Dialysis and BioSentry Biopsy Tract Sealant System sales Net sales increased 5.7% on a pro-forma basis when excluding Dialysis and BioSentry, compared to the prior...